Form 8-K - Current report:
SEC Accession No. 0000950103-24-016076
Filing Date
2024-11-07
Accepted
2024-11-07 16:05:32
Documents
13
Period of Report
2024-11-01
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp220472_8k.htm   iXBRL 8-K 24365
  Complete submission text file 0000950103-24-016076.txt   195272

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pgen-20241101.xsd EX-101.SCH 3000
3 XBRL LABEL FILE pgen-20241101_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE pgen-20241101_pre.xml EX-101.PRE 22349
15 EXTRACTED XBRL INSTANCE DOCUMENT dp220472_8k_htm.xml XML 3551
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 241435513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)